Skip to main content

Advanced Glycation End Products (AGEs) Activity Assay Kit (ab273298) can be used for the semi-quantitative estimation of fluorescent AGEs levels in Biological Fluids.

Be the first to review this product! Submit a review

Images

Functional Studies - Advanced Glycation End Products (AGEs) Assay Kit (AB273298), expandable thumbnail
  • Functional Studies - Advanced Glycation End Products (AGEs) Assay Kit (AB273298), expandable thumbnail

Publications

Key facts

Detection method

Fluorescent

Sample types

Serum

Assay type

Semi-quantitative

Alternative names

What's included?

100 Test
Components
AGE Positive Control Protein
1 x 500 µL
BSA Standard I
1 x 500 µL
Wash Buffer II
1 x 50 mL

Recommended products

Advanced Glycation End Products (AGEs) Activity Assay Kit (ab273298) can be used for the semi-quantitative estimation of fluorescent AGEs levels in Biological Fluids.

Alternative names

Key facts

Detection method

Fluorescent

Sample types

Serum

Assay type

Semi-quantitative

Assay Platform

Microplate

Storage

Shipped at conditions

Blue Ice

Appropriate short-term storage conditions

-20°C

Appropriate long-term storage conditions

-20°C

Storage information

-20°C

Notes

Advanced Glycation End Products (AGEs) Activity Assay Kit (ab273298) can be used for the semi-quantitative estimation of fluorescent AGEs levels in Biological Fluids. The assay is based on the characteristic fluorescence (Ex/Em= 360/460 nm), a characteristic that is shared by almost all AGEs. The proprietary composition of the Assay Buffer specifically distinguishes between AGEs and non-oxidized proteins. The one-step assay uses oxidized Bovine Serum Albumin (AGE-BSA) as a Positive Control. BSA is used as Background Control and its fluorescence under assay conditions is defined as 1 relative fluorescence intensity in arbitrary units (AU or RFUSample/ RFUBackground).

This product is manufactured by BioVision, an Abcam company and was previously called K929 Advanced Glycation End Products (AGEs) Assay Kit. K929-100 is the same size as the 100 test size of ab273298.

Supplementary info

This supplementary information is collated from multiple sources and compiled automatically.

Activity summary

Advanced Glycation End-products (AGEs) are highly reactive compounds formed when reducing sugars non-enzymatically bind to proteins lipids or nucleic acids. They are often referred to as AGE products or AGE-BSA when in the form of bovine serum albumin (BSA). The molecular weight of AGE compounds can vary significantly due to the diversity of glycation products. AGEs express in various tissues but accumulate more in aging tissues and in certain pathological states. Detection of AGE products often utilizes AGE ELISA assays or fluorescence-based methods to measure AGE-BSA.

Biological function summary

AGE compounds affect cellular and tissue functions by altering structural proteins and increasing oxidative stress. While not a component of a specific complex AGEs catalyze cross-linking of proteins like collagen impacting tissue elasticity. The binding of AGEs to receptors such as RAGE (Receptor for Advanced Glycation End-products) triggers inflammatory pathways and oxidative stress. This interaction fuels the damaging effects of AGEs in biological systems which are assayed through AGE assays.

Pathways

AGE compounds influence several critical biological pathways particularly the NF-kB and MAPK pathways. These pathways mediate inflammation and cellular stress responses. The interaction with RAGE also affects signaling with related proteins like S100/calgranulins which further activate pro-inflammatory responses. The alteration of these pathways by AGE compounds highlights their significance in cellular dysfunction and age-related conditions.

Associated diseases and disorders

AGE compounds play significant roles in the progression of diabetes and cardiovascular disease. In diabetes AGEs contribute to complications by modifying vascular structure and function where they link with proteins such as HbA1c in glycation. In cardiovascular disease AGE accumulation in vascular tissues enhances vascular stiffness and atherosclerotic lesion formation. The AGE-RAGE interaction perpetuates chronic inflammation further exacerbating these conditions.

Product promise

We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.

In the unlikely event of one of our products not working as expected, you are covered by our product promise.

Full details and terms and conditions can be found here:
Terms & Conditions.

2 product images

  • Functional Studies - Advanced Glycation End Products (AGEs) Assay Kit (ab273298), expandable thumbnail

    Functional Studies - Advanced Glycation End Products (AGEs) Assay Kit (ab273298)

    AGE and BSA standard curve.

    Typical standard curve – data provided for demonstration purposes only. A new standard curve must be generated for each assay performed.

    AGEs-Positive (AGE-BSA) fluorescence versus BSA. The assay can distinguish both species (AGEs and non-oxidized proteins).

  • Functional Studies - Advanced Glycation End Products (AGEs) Assay Kit (ab273298), expandable thumbnail

    Functional Studies - Advanced Glycation End Products (AGEs) Assay Kit (ab273298)

    AGE activity in serum samples.

    AGEs amount in Pooled Human Serum from healthy donors (4 μg serum protein), Human Diabetic Serum (4 μg serum protein) and Human Urine from healthy donor.

Downloads

Product protocols

For this product, it's our understanding that no specific protocols are required. You can:

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com